Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy

AIMS: Exogenous atrial natriuretic peptide (ANP) may be a logical treatment for heart failure (HF) patients with ANP deficiency. Lower ANP concentrations may result from HF with preserved ejection fraction (HFpEF), which also results in lower brain natriuretic peptide levels in HFpEF relative to HF...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:ESC Heart Fail
Päätekijät: Matsumoto, Shingo, Nakazawa, Gaku, Ohno, Yohei, Ishihara, Mai, Sakai, Katsuaki, Nakamura, Norihito, Murakami, Tsutomu, Natsumeda, Makoto, Kabuki, Takayuki, Shibata, Atsushi, Kida, Keisuke, Konishi, Masaaki, Ishii, Shunsuke, Ikeda, Takanori, Ikari, Yuji
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Original Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7754892/
https://ncbi.nlm.nih.gov/pubmed/33037750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13042
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia